Xue-Qiao Zhao Selected Research

Myocardial Infarction

1/2022	Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction.
11/2020	High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction.
7/2020	Atherosclerosis, its risk factors, and cognitive impairment in older adults.
1/2019	Usefulness of the CHA2DS2-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
10/2018	Combination of Amino-Terminal Pro- BNP , Estimated GFR , and High-Sensitivity CRP for Predicting Cardiorenal Syndrome Type 1 in Acute Myocardial Infarction Patients.
1/2018	Low T3 syndrome improves risk prediction of in-hospital cardiovascular death in patients with acute myocardial infarction.
10/2013	Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes).
1/2013	Levels of cholesterol in small LDL particles predict atherosclerosis progression and incident CHD in the HDL-Atherosclerosis Treatment Study (HATS).
4/2004	Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial.
1/2004	Predictors of repeat revascularization after nonemergent, first percutaneous coronary intervention in the community.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xue-Qiao Zhao Research Topics

Disease

18	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 10/2002
15	Atherosclerosis 03/2020 - 02/2004
13	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 10/2002
11	Myocardial Infarction 01/2022 - 02/2003
11	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 07/2007
10	Acute Coronary Syndrome 02/2022 - 04/2004
9	Thrombosis (Thrombus) 01/2021 - 05/2005
8	Carotid Artery Diseases 09/2021 - 09/2011
7	Pathologic Constriction (Stenosis) 09/2021 - 11/2004
6	Atherosclerotic Plaque (Atheroma) 01/2021 - 06/2007
6	Coronary Stenosis (Coronary Artery Stenosis) 05/2014 - 03/2007
4	Insulin Resistance 11/2021 - 07/2007
4	Vascular Diseases (Vascular Disease) 11/2020 - 03/2007
4	Stroke (Strokes) 07/2020 - 01/2013
3	Inflammation (Inflammations) 04/2021 - 03/2007
3	Hypertension (High Blood Pressure) 11/2020 - 02/2003
3	Coronary Disease (Coronary Heart Disease) 11/2017 - 02/2003
3	Dyslipidemias (Dyslipidemia) 11/2017 - 07/2007
3	Diabetes Mellitus 01/2017 - 02/2004
3	Carotid Stenosis (Carotid Artery Stenosis) 09/2011 - 03/2008
2	Rupture 04/2021 - 09/2011
2	ST Elevation Myocardial Infarction 01/2021 - 01/2019
2	Death (Near-Death Experience) 11/2020 - 07/2020
2	Non-ST Elevated Myocardial Infarction 01/2019 - 05/2005
2	Unstable Angina 01/2019 - 05/2005
2	Hemorrhage 11/2014 - 01/2006
2	Ischemia 01/2013 - 04/2004
2	Aortic Valve Stenosis (Aortic Stenosis) 04/2005 - 04/2004
1	Infarction (Infarctions) 02/2022
1	Hyperlipidemias (Hyperlipidemia) 11/2020
1	Overweight 07/2020
1	Cognitive Dysfunction 07/2020
1	Atrial Fibrillation 01/2019
1	Heart Diseases (Heart Disease) 11/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2014
1	Ischemic Stroke 10/2013

Drug/Important Bio-Agent (IBA)

25	LipidsIBA 04/2021 - 01/2006
16	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2021 - 10/2002
12	Triglycerides (Triacylglycerol)IBA 02/2022 - 02/2004
12	HDL CholesterolIBA 01/2018 - 10/2002
11	LDL CholesterolIBA 02/2022 - 02/2004
11	HDL LipoproteinsIBA 02/2016 - 10/2002
10	oxidized low density lipoproteinIBA 02/2022 - 02/2003
9	CholesterolIBA 11/2020 - 03/2007
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2020 - 09/2008
8	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 07/2007
6	Simvastatin (Zocor)FDA LinkGeneric 09/2016 - 10/2002
6	Lipoproteins (Lipoprotein)IBA 05/2014 - 03/2007
4	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 10/2018
4	CalciumIBA 11/2021 - 04/2005
4	cytidylyl-(3'-5')-cytidine (CpC)IBA 09/2021 - 09/2011
4	Atorvastatin (Lipitor)FDA Link 02/2016 - 08/2007
4	LDL Lipoproteins (beta Lipoproteins)IBA 05/2014 - 12/2006
4	Pharmaceutical PreparationsIBA 03/2013 - 12/2006
4	ApolipoproteinsIBA 09/2011 - 08/2007
4	PlacebosIBA 09/2011 - 02/2004
3	C-Reactive ProteinIBA 09/2021 - 10/2018
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 05/2005
3	Lipoprotein(a)IBA 01/2018 - 11/2014
3	FatsIBA 09/2014 - 12/2009
3	Proteins (Proteins, Gene)FDA Link 07/2010 - 03/2007
2	Troponin IIBA 02/2022 - 07/2020
2	Insulin (Novolin)FDA Link 09/2021 - 07/2007
2	Apolipoproteins B (ApoB)IBA 09/2021 - 03/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 04/2004
2	Rosuvastatin Calcium (Crestor)FDA Link 09/2019 - 03/2008
2	Colestipol (Colestid)FDA LinkGeneric 09/2016 - 09/2014
2	Lovastatin (Mevacor)FDA LinkGeneric 09/2016 - 09/2014
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2014 - 03/2008
2	Blood Glucose (Blood Sugar)IBA 02/2013 - 07/2007
2	Colesevelam Hydrochloride (Welchol)FDA Link 12/2007 - 08/2007
2	Glycoproteins (Glycoprotein)IBA 05/2005 - 04/2004
2	CreatinineIBA 04/2004 - 01/2004
2	AntioxidantsIBA 02/2004 - 10/2002
2	VitaminsIBA 02/2004 - 10/2002
1	MyoglobinIBA 02/2022
1	MB Form Creatine KinaseIBA 02/2022
1	alirocumabIBA 04/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	PCSK9 InhibitorsIBA 01/2021
1	ProteomeIBA 01/2021
1	Proprotein Convertase 9IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	omega-Chloroacetophenone (Mace)IBA 01/2019
1	Peptides (Polypeptides)IBA 10/2018
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2018
1	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2017
1	Ezetimibe (Zetia)FDA Link 09/2016
1	Methionine (L-Methionine)FDA Link 05/2014
1	Peroxidase (Myeloperoxidase)IBA 05/2014
1	SterolsIBA 05/2014
1	Tyrosine (L-Tyrosine)FDA Link 05/2014
1	Bile Acids and Salts (Bile Acids)IBA 05/2014
1	VLDL LipoproteinsIBA 05/2014
1	IDL Lipoproteins (Lipoprotein, IDL)IBA 05/2014

Therapy/Procedure

24	Therapeutics 01/2020 - 10/2002
4	Percutaneous Coronary Intervention 01/2022 - 01/2019
1	Aftercare (After-Treatment) 04/2021
1	Patient Readmission 11/2020
1	Secondary Prevention 01/2020